| Protein kinase CK2α as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia JS Kim, JI Eom, JW Cheong, AJ Choi, JK Lee, WI Yang, YH Min Clinical cancer research 13 (3), 1019-1028, 2007 | 239 | 2007 |
| Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL) YR Kim, JS Kim, YH Min, DH Yoon, HJ Shin, YC Mun, Y Park, YR Do, ... Journal of Hematology & Oncology 5, 1-9, 2012 | 119 | 2012 |
| Predictive factors of mortality in population of patients with paroxysmal nocturnal hemoglobinuria (PNH): results from a Korean PNH registry JH Jang, JS Kim, SS Yoon, JH Lee, YK Kim, DY Jo, J Chung, SK Sohn, ... Journal of Korean medical science 31 (2), 214, 2016 | 79 | 2016 |
| Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous … JS Kim, K Kim, JW Cheong, YH Min, C Suh, H Kim, DY Jo, HM Ryoo, ... Biology of Blood and Marrow Transplantation 15 (4), 463-470, 2009 | 78 | 2009 |
| Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy YR Kim, JS Kim, SJ Kim, HA Jung, SJ Kim, WS Kim, HW Lee, HS Eom, ... Journal of hematology & oncology 4, 1-9, 2011 | 46 | 2011 |
| Inhibition of CK2α and PI3K/Akt synergistically induces apoptosis of CD34+ CD38− leukaemia cells while sparing haematopoietic stem cells JW Cheong, YH Min, JI Eom, SJ Kim, HK Jeung, JS Kim Anticancer research 30 (11), 4625-4634, 2010 | 43 | 2010 |
| Apicidin potentiates the imatinib‐induced apoptosis of Bcr–Abl‐positive human leukaemia cells by enhancing the activation of mitochondria‐dependent caspase cascades JS Kim, HK Jeung, JW Cheong, H Maeng, ST Lee, JS Hahn, YW Ko, ... British journal of haematology 124 (2), 166-178, 2004 | 43 | 2004 |
| A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma JE Jang, YR Kim, SJ Kim, H Cho, H Chung, JY Lee, H Park, Y Kim, ... European Journal of Cancer 57, 127-135, 2016 | 34 | 2016 |
| Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma H Cho, SH Kim, SJ Kim, JH Chang, WI Yang, CO Suh, YR Kim, JE Jang, ... Oncotarget 8 (50), 87317, 2017 | 30 | 2017 |
| Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma JS Kim, JS Hahn, SY Park, Y Kim, IH Park, CK Lee, JW Cheong, ST Lee, ... Yonsei medical journal 48 (1), 78, 2007 | 30 | 2007 |
| Adaptive natural killer cells facilitate effector functions of daratumumab in multiple myeloma H Cho, KH Kim, H Lee, CG Kim, H Chung, YS Choi, SH Park, JW Cheong, ... Clinical Cancer Research 27 (10), 2947-2958, 2021 | 28 | 2021 |
| The use of the complement inhibitor eculizumab (Soliris®) for treating Korean patients with paroxysmal nocturnal hemoglobinuria JS Kim, JW Lee, BK Kim, JH Lee, J Chung The Korean journal of hematology 45 (4), 269, 2010 | 26 | 2010 |
| The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160) SH Jung, JJ Lee, K Kim, C Suh, DH Yoon, CK Min, SK Sohn, CW Choi, ... Oncotarget 8 (45), 79517, 2017 | 23 | 2017 |
| Pretreatment lymphopenia, poor performance status, and early courses of therapy are risk factors for severe bacterial infection in patients with multiple myeloma during … SY Hyun, SH Han, SJ Kim, JE Jang, Y Kim, H Cho, JY Lee, JW Cheong, ... Journal of Korean medical science 31 (4), 510, 2016 | 22 | 2016 |
| Monoclonal and polyclonal gammopathy measured by serum free light chain and immunofixation subdivide the clinical outcomes of diffuse large B-cell lymphoma according to … YR Kim, SJ Kim, JW Cheong, Y Kim, JE Jang, JY Lee, YH Min, JW Song, ... Annals of hematology 93, 1867-1877, 2014 | 22 | 2014 |
| Clinical characteristics and outcome for hepatitis C virus-positive diffuse large B-cell lymphoma BB Park, JS Kim, YY Lee, HJ Kang, BY Ryoo, JH Kang, HY Kim, BS Kim, ... Leukemia & lymphoma 49 (1), 88-94, 2008 | 22 | 2008 |
| Distinct subgroups of paroxysmal nocturnal hemoglobinuria (PNH) with cytopenia: results from South Korean National PNH Registry JS Kim, JH Jang, SS Yoon, JH Lee, YK Kim, DY Jo, JS Chung, SK Sohn, ... Annals of hematology 95, 125-133, 2016 | 21 | 2016 |
| High-dose etoposide plus granulocyte colony-stimulating factor as an effective chemomobilization regimen for autologous stem cell transplantation in patients with non-Hodgkin … SY Hyun, JW Cheong, SJ Kim, YH Min, DH Yang, JS Ahn, WS Lee, ... Biology of Blood and Marrow Transplantation 20 (1), 73-79, 2014 | 20 | 2014 |
| The role of upfront autologous stem cell transplantation in high‐risk younger patients with primary central nervous system lymphoma H Cho, JH Chang, YR Kim, SJ Kim, H Chung, H Park, JY Lee, JE Jang, ... British journal of haematology 174 (3), 444-453, 2016 | 19 | 2016 |
| A successful treatment of relapsed primary CNS lymphoma patient with intraventricular rituximab followed by high-dose chemotherapy with autologous stem cell rescue SJ Hong, JS Kim, JH Chang, KM Kim, SJ Kim, HW Lee, JW Cheong, ... Yonsei medical journal 50 (2), 280, 2009 | 19 | 2009 |
